Related references
Note: Only part of the references are listed.Extended-spectrum β-Lactamase-Producing Enterobacteriaceae Causing Nosocomial Infections in Mexico. A Retrospective and Multicenter Study
Jesus Silva-Sanchez et al.
ARCHIVES OF MEDICAL RESEARCH (2011)
Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases
U. -I. Wu et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Molecular characterization and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates at a tertiary-care centre in Monterrey, Mexico
Elvira Garza-Gonzalez et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Clinical and economic outcomes associated with community-acquired intra-abdominal infections caused by extended spectrum beta-lactamase (ESBL) producing bacteria in China
Bijie Hu et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies
Yong Chong et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome
Carlota Gudiol et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies
Enrico M. Trecarichi et al.
JOURNAL OF INFECTION (2009)
Risk-factors for emerging bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli
J. Rodriguez-Bano et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae A case-control study
Juan L. Mosqueda-Gomez et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2008)
Infections due to Escherichia coli producing extended-spectrum β-lactamase among hospitatised patients:: factors influencing mortality
C. Pena et al.
JOURNAL OF HOSPITAL INFECTION (2008)
SHV-type Extended-spectrum ss-lactamase (ESBL) are encoded in related plasmids from enterobacteria clinical isolates from Mexico
Ulises Garza-Ramos et al.
SALUD PUBLICA DE MEXICO (2007)
The continuing challenge of ESBLs
Federico Perez et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Extended-spectrum β-lactamases and clinical outcomes:: Current data
R Ramphal et al.
CLINICAL INFECTIOUS DISEASES (2006)
Risk-factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalised patients
C Peña et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae -: Variability by site of infection
EP Hyle et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Bacteremia in patients with hematological malignancies
FD Wang et al.
CHEMOTHERAPY (2005)
Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain
A Valverde et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Outbreak of infection with extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Mexican hospital
J Silva et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for infection and impact of resistance on outcomes
E Lautenbach et al.
CLINICAL INFECTIOUS DISEASES (2001)
New tools in diagnosing catheter-related infections
F Blot et al.
SUPPORTIVE CARE IN CANCER (2000)
Share Paper
